4//SEC Filing
Gonyer David A 4
Accession 0001209191-20-063366
CIK 0001403708other
Filed
Dec 13, 7:00 PM ET
Accepted
Dec 14, 8:58 PM ET
Size
7.1 KB
Accession
0001209191-20-063366
Insider Transaction Report
Form 4
Evoke Pharma IncEVOK
Gonyer David A
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2020-12-11$2.90/sh−48,046$139,333→ 363,736 total - Sale
Common Stock
2020-12-14$2.94/sh−23,954$70,425→ 339,782 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.90 to $2.93. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.93 to $2.97. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Evoke Pharma Inc
CIK 0001403708
Entity typeother
Related Parties
1- filerCIK 0001578768
Filing Metadata
- Form type
- 4
- Filed
- Dec 13, 7:00 PM ET
- Accepted
- Dec 14, 8:58 PM ET
- Size
- 7.1 KB